ESTaid Corp. (KOSDAQ:239340)
South Korea · Delayed Price · Currency is KRW 2,380.00
-60.00 (-2.46%)
Last updated: Aug 6, 2025
Revance Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
| 16,702 | 16,399 | 13,837 | 22,922 | 28,780 | 23,814 | Upgrade | |
Revenue Growth (YoY) | 21.63% | 18.51% | -39.63% | -20.36% | 20.85% | -3.51% | Upgrade |
Cost of Revenue | 16.25 | 15.73 | 2.93 | 5.38 | 3.86 | 3.2 | Upgrade |
Gross Profit | 16,685 | 16,383 | 13,834 | 22,917 | 28,777 | 23,811 | Upgrade |
Selling, General & Admin | 22,564 | 20,276 | 18,772 | 22,451 | 20,713 | 21,005 | Upgrade |
Other Operating Expenses | 37.49 | 37.02 | 92.55 | 74.55 | 56 | 63.9 | Upgrade |
Operating Expenses | 23,475 | 21,189 | 20,011 | 23,614 | 22,032 | 22,768 | Upgrade |
Operating Income | -6,790 | -4,805 | -6,176 | -697.16 | 6,745 | 1,043 | Upgrade |
Interest Expense | -58.76 | -51.91 | -120.87 | -136.25 | -129.95 | -25.2 | Upgrade |
Interest & Investment Income | 290.01 | 368.51 | 691.03 | 397.94 | 466.52 | 400.12 | Upgrade |
Earnings From Equity Investments | -625.23 | -473.78 | -1,440 | -62.76 | -196.65 | - | Upgrade |
Currency Exchange Gain (Loss) | 146.12 | 136.73 | -3.93 | 11.5 | 11.63 | -10.57 | Upgrade |
Other Non Operating Income (Expenses) | 29.8 | 69.33 | 27.87 | -87.66 | -1,481 | 80.6 | Upgrade |
EBT Excluding Unusual Items | -7,008 | -4,757 | -7,022 | -574.39 | 5,415 | 1,488 | Upgrade |
Impairment of Goodwill | - | - | - | -129 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 21.09 | 48.78 | 187.51 | 42.49 | 2,238 | 252.84 | Upgrade |
Gain (Loss) on Sale of Assets | -2.02 | -2.02 | 0.15 | 14.35 | 10.84 | -1.61 | Upgrade |
Asset Writedown | -231.94 | -231.94 | - | - | - | -14.02 | Upgrade |
Pretax Income | -7,221 | -4,942 | -6,834 | -646.55 | 7,664 | 1,725 | Upgrade |
Income Tax Expense | 50.09 | 50.09 | 376.29 | 674.07 | 624.82 | 325.29 | Upgrade |
Earnings From Continuing Operations | -7,271 | -4,992 | -7,211 | -1,321 | 7,039 | 1,400 | Upgrade |
Earnings From Discontinued Operations | - | - | - | -1,150 | -3,154 | -620.36 | Upgrade |
Net Income to Company | -7,271 | -4,992 | -7,211 | -2,470 | 3,886 | 779.81 | Upgrade |
Minority Interest in Earnings | 67.88 | -40.71 | -49.17 | 436.87 | 1,296 | 410.23 | Upgrade |
Net Income | -7,203 | -5,033 | -7,260 | -2,034 | 5,181 | 1,190 | Upgrade |
Net Income to Common | -7,203 | -5,033 | -7,260 | -2,034 | 5,181 | 1,190 | Upgrade |
Net Income Growth | - | - | - | - | 335.40% | - | Upgrade |
Shares Outstanding (Basic) | 27 | 27 | 27 | 27 | 27 | 27 | Upgrade |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 27 | 27 | Upgrade |
Shares Change (YoY) | - | - | 0.83% | -0.64% | 0.28% | 17.66% | Upgrade |
EPS (Basic) | -266.99 | -186.53 | -269.08 | -76.00 | 192.40 | 44.31 | Upgrade |
EPS (Diluted) | -267.00 | -187.00 | -269.08 | -76.00 | 192.40 | 44.31 | Upgrade |
EPS Growth | - | - | - | - | 334.18% | - | Upgrade |
Free Cash Flow | -3,612 | -1,040 | 1,057 | 2,128 | 4,345 | 2,556 | Upgrade |
Free Cash Flow Per Share | -133.89 | -38.53 | 39.18 | 79.53 | 161.35 | 95.16 | Upgrade |
Gross Margin | 99.90% | 99.90% | 99.98% | 99.98% | 99.99% | 99.99% | Upgrade |
Operating Margin | -40.66% | -29.30% | -44.63% | -3.04% | 23.43% | 4.38% | Upgrade |
Profit Margin | -43.13% | -30.69% | -52.46% | -8.87% | 18.00% | 5.00% | Upgrade |
Free Cash Flow Margin | -21.63% | -6.34% | 7.64% | 9.28% | 15.10% | 10.73% | Upgrade |
EBITDA | -5,916 | -3,930 | -5,030 | 419.66 | 8,013 | 2,373 | Upgrade |
EBITDA Margin | -35.42% | -23.97% | -36.35% | 1.83% | 27.84% | 9.96% | Upgrade |
D&A For EBITDA | 874.07 | 875.07 | 1,146 | 1,117 | 1,268 | 1,329 | Upgrade |
EBIT | -6,790 | -4,805 | -6,176 | -697.16 | 6,745 | 1,043 | Upgrade |
EBIT Margin | -40.66% | -29.30% | -44.63% | -3.04% | 23.43% | 4.38% | Upgrade |
Effective Tax Rate | - | - | - | - | 8.15% | 18.85% | Upgrade |
Advertising Expenses | - | 379.14 | 940.88 | 1,720 | 2,848 | 3,598 | Upgrade |
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.